327.00
-0.24%
Close of 9 Nov 2026, in PLN
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Synektik
Its shares trade on GPW under the ticker SNT.WA. It has been listed since 9 August 2011. In the fiscal year to 31 December 2025, it reported revenue of PLN 681.3m and net income of PLN 102.2m. At that date it held total assets of PLN 486.6m and shareholders' equity of PLN 222.8m.
Synektik SA provides medical and information technology solutions. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2011-08-09. The company produces PACS software which allows running a diagnostic imaging laboratory. The company runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The firm sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 9 Aug 2011
- Employees
- 145
- Website
- synektik.com.pl ↗
Leadership
Pay as last reported
- Mr. Mariusz KsiazekChairman of the Supervisory Board, since 2018PLN 9,500
- Mr. Cezary KozaneckiChairman of the Management Board, Chief Executive OfficerPLN 1.4m
- Mr. Wieslaw LatalaVice Chairman of the Supervisory Board, since 2017PLN 9,500
- Mr. Dariusz KoreckiVice Chairman of the Management BoardPLN 726,000
- Ms. Katarzyna DebowskaChief Accounting Officer
- Mr. Artur OstrowskiMember of the Management BoardPLN 778,500
- Mr. Tomasz WrobelMember of the Management Board
- Ms. Sawa ZarebinskaSecretary of the Supervisory Board, since 2011PLN 19,000
- Mr. Michal DobakMember of the Supervisory Board
- Mr. Andrzej JacaszekMember of the Supervisory Board
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Synektik SA's PACS software enables efficient diagnostic imaging laboratory operations in Poland.
- The company's partnership with Siemens enhances its medical equipment distribution network.
- Synektik SA's research laboratory conducts specialized X-ray equipment testing in Warsaw.
Weaknesses
- Synektik SA's IPO in 2011 may limit recent capital for expansion in the Health Care sector.
- The company's focus on Warsaw-based operations could restrict broader market reach.
- Synektik SA's reliance on Miedzynarodowe Centra Medyczne Inwestycje Sp z o o for medical services.
Opportunities
- Synektik SA can expand its PACS software solutions to other European Health Care providers.
- Growing demand for medical imaging equipment in Poland presents new market opportunities.
- Synektik SA's research laboratory can develop new X-ray testing services for international clients.
Threats
- Competition from established medical technology firms in the Polish Health Care sector.
- Regulatory changes in the Polish Health Care industry could impact Synektik SA's operations.
- Economic downturns in Poland may reduce healthcare spending and affect Synektik SA's revenue.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.